Wed, Jul 23, 2014, 8:54 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Exelixis, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • erniewerner erniewerner Dec 8, 2012 10:25 AM Flag

    EXEL:Some great news and we take off

    "A new study is reporting "unprecedented" results..." It is a recent article, but not a new study. This is the CRPC cohort from the RDT originally reported on in Feb 2011. There will be updates and phase 2 results fairly often, but the market is really only impressed by the results of randomized controlled trials. In that category, next up is the EXAM survival analysis followed by Comet 2, both in the 12-18 month time frame.

3.78+0.19(+5.29%)Jul 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NasdaqGSWed, Jul 23, 2014 4:00 PM EDT
Gilead Sciences Inc.
NasdaqGSWed, Jul 23, 2014 3:59 PM EDT